Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity-Reference-Cited by-同舟云学术

Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity

Published:2016-06-27 Issue: Volume:3 Page:
ISSN:2297-055X
Container-title:Frontiers in Cardiovascular Medicine
language:
Short-container-title:Front. Cardiovasc. Med.

Author:

Garcia John,Tahiliani Jackie,Johnson Nicole Marie,Aguilar Sienna,Beltran Daniel,Daly Amy,Decker Emily,Haverfield Eden,Herrera Blanca,Murillo Laura,Nykamp Keith,Topper Scott

Publisher

Frontiers Media SA

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Clinical validity and clinical utility of genetic tests;Burke;Curr Protoc Hum Genet,2009

2. EGAPP Working Group. Outcomes of interest in evidence-based evaluations of genetic tests;Botkin;Genet Med,2010

3. Genetic tests: clinical validity and clinical utility;Burke;Curr Protoc Hum Genet,2014

4. Creatine kinase adenosine triphosphate and phosphocreatine energy supply in a single kindred of patients with hypertrophic cardiomyopathy;Abraham;Am J Cardiol,2013

5. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu – Val mutation and a 403Arg – Gln mutation;Epstein;Circulation,1992

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Spectrum of Minor Genes in Cardiomyopathies: A Narrative Review;International Journal of Molecular Sciences;2024-09-10

2. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Circulation;2024-06-04

3. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy;Journal of the American College of Cardiology;2024-06

4. Long QTc in hypertrophic cardiomyopathy: A consequence of structural myocardial damage or a distinct genetic disease?;Frontiers in Cardiovascular Medicine;2023-04-05

5. Brugada Syndrome: From Molecular Mechanisms and Genetics to Risk Stratification;International Journal of Molecular Sciences;2023-02-07